Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new global alliance launches to end AIDS in children by 2030. Currently, only half of children with HIV are on lifesaving treatment.
After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.
The current leading suspect is an adenovirus, but much more remains to be learned.
The approval makes this the first single-pill regimen containing dolutegravir available in a water-dispersible formulation.
The exhibit tells the story of her life, says Kia LaBeija, and that includes her mom, HIV, ballroom, love and a double rainbow. [SLIDESHOW]
In the second session of Leadership Exchange LIVE: BEEEBAH Edition Ciarra “Ci Ci” Covin is joined by Marielle Gross, MD, MBE.
Noninvasive imaging may be the best way to screen for NAFLD in this population.
A study showed that as HIV treatment expanded, teens lost fewer parents to the virus.
Biktarvy is now available for small children.
A high-quality trial should improve access to dolutegravir for children worldwide.
Vaccine effectiveness for children ages 5 to 11 was 91%, and serious side effects are rare.
The Food and Drug Administration approved the single-pill treatment for children weighing at least 30 pounds.
Whether or not they want kids, access to accurate information and the tools to conceive—or not—are essential for people living with HIV.
The Pfizer-BioNTech vaccine was 100% effective in a study of adolescents; trials for younger children are now underway.
New guidelines from the Department of Health and Human Services went into effect immediately.
Compared with efavirenz-based regimens, dolutegravir-containing ones resulted in fewer switches and better viral control.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.